|
|
||||||||
1Weis Center for Research and 2Department of Medicine, Geisinger Medical Center, Danville, Pennsylvania 17822; and 3Division of Cardiology, Department of Internal Medicine, University of Virginia Health Science Center, Charlottesville, Virginia 22908
Submitted 23 October 2003 ; accepted in final form 12 December 2003
Phospholemman (PLM) expression was increased in rat hearts after myocardial infarction (MI). Overexpression of PLM in normal adult rat cardiac myocytes altered contractile function and cytosolic Ca2+ concentration ([Ca2+]i) homeostasis in a manner similar to that observed in post-MI myocytes. In this study, we tested whether PLM downregulation in normal adult rat myocytes resulted in contractility and [Ca2+]i transient changes opposite to those observed in post-MI myocytes. Compared with control myocytes infected with adenovirus (Adv) expressing green fluorescent protein (GFP) alone, myocytes infected with Adv expressing both GFP and rat antisense PLM (rASPLM) had 23% less PLM protein (P < 0.012) at 3 days, but no differences were found in sarcoplasmic reticulum (SR) Ca2+-ATPase, Na+/Ca2+ exchanger (NCX1), Na+-K+-ATPase, and calsequestrin levels. SR Ca2+ uptake and whole cell capacitance were not affected by rASPLM treatment. Relaxation from caffeine-induced contracture was faster, and NCX1 current amplitudes were higher in rASPLM myocytes, indicating that PLM downregulation enhanced NCX1 activity. In native rat cardiac myocytes, coimmunoprecipitation experiments indicated an association of PLM with NCX1. At 0.6 mM [Ca2+]o, rASPLM myocytes had significantly (P < 0.003) lower contraction and [Ca2+]i transient amplitudes than control GFP myocytes. At 5 mM [Ca2+]o, both contraction and [Ca2+]i transient amplitudes were higher in rASPLM myocytes. This pattern of contractile and [Ca2+]i transient behavior in rASPLM myocytes was opposite to that observed in post-MI rat myocytes. We conclude that downregulation of PLM in normal rat cardiac myocytes enhanced NCX1 function and affected [Ca2+]i transient and contraction amplitudes. We suggest that PLM downregulation offers a potential therapeutic strategy for ameliorating contractile abnormalities in MI myocytes.
adult rat myocyte culture; patch clamp; fura-2; edge detection; excitation-contraction coupling
This article has been cited by other articles:
![]() |
J. R. Bell, E. Kennington, W. Fuller, K. Dighe, P. Donoghue, J. E. Clark, L.-G. Jia, A. L. Tucker, J. Randall Moorman, M. S. Marber, et al. Characterization of the phospholemman knockout mouse heart: depressed left ventricular function with increased Na-K-ATPase activity Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H613 - H621. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Y. CHEUNG, L. I. ROTHBLUM, J. R. MOORMAN, A. L. TUCKER, J. SONG, B. A. AHLERS, L. L. CARL, J. WANG, and X.-Q. ZHANG Regulation of Cardiac Na+/Ca2+ Exchanger by Phospholemman Ann. N.Y. Acad. Sci., March 1, 2007; 1099(1): 119 - 134. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Tucker, J. Song, X.-Q. Zhang, J. Wang, B. A. Ahlers, L. L. Carl, J. P. Mounsey, J. R. Moorman, L. I. Rothblum, and J. Y. Cheung Altered contractility and [Ca2+]i homeostasis in phospholemman-deficient murine myocytes: role of Na+/Ca2+ exchange Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2199 - H2209. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Beevers and A. Kukol Secondary structure, orientation, and oligomerization of phospholemman, a cardiac transmembrane protein Protein Sci., May 1, 2006; 15(5): 1127 - 1132. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Geering FXYD proteins: new regulators of Na-K-ATPase Am J Physiol Renal Physiol, February 1, 2006; 290(2): F241 - F250. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-Q. Zhang, J. R. Moorman, B. A. Ahlers, L. L. Carl, D. E. Lake, J. Song, J. P. Mounsey, A. L. Tucker, Y.-m. Chan, L. I. Rothblum, et al. Phospholemman overexpression inhibits Na+-K+-ATPase in adult rat cardiac myocytes: relevance to decreased Na+ pump activity in postinfarction myocytes J Appl Physiol, January 1, 2006; 100(1): 212 - 220. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Reis, L. Zhang, S. Cala, K. N. Jew, L. C. Mace, L. Chung, R. L. Moore, and Y.-C. Ng Expression of phospholemman and its association with Na+-K+-ATPase in skeletal muscle: effects of aging and exercise training J Appl Physiol, October 1, 2005; 99(4): 1508 - 1515. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Bossuyt, X. Ai, J. R. Moorman, S. M. Pogwizd, and D. M. Bers Expression and Phosphorylation of the Na-Pump Regulatory Subunit Phospholemman in Heart Failure Circ. Res., September 16, 2005; 97(6): 558 - 565. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Song, X.-Q. Zhang, B. A. Ahlers, L. L. Carl, J. Wang, L. I. Rothblum, R. C. Stahl, J. P. Mounsey, A. L. Tucker, J. R. Moorman, et al. Serine 68 of phospholemman is critical in modulation of contractility, [Ca2+]i transients, and Na+/Ca2+ exchange in adult rat cardiac myocytes Am J Physiol Heart Circ Physiol, May 1, 2005; 288(5): H2342 - H2354. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-G. Jia, C. Donnet, R. C. Bogaev, R. J. Blatt, C. E. McKinney, K. H. Day, S. S. Berr, L. R. Jones, J. R. Moorman, K. J. Sweadner, et al. Hypertrophy, increased ejection fraction, and reduced Na-K-ATPase activity in phospholemman-deficient mice Am J Physiol Heart Circ Physiol, April 1, 2005; 288(4): H1982 - H1988. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Suarez, B. Gloss, D. D. Belke, Y. Hu, B. Scott, T. Dieterle, Y.-K. Kim, M. L. Valencik, J. A. McDonald, and W. H. Dillmann Doxycycline inducible expression of SERCA2a improves calcium handling and reverts cardiac dysfunction in pressure overload-induced cardiac hypertrophy Am J Physiol Heart Circ Physiol, November 1, 2004; 287(5): H2164 - H2172. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |